The role of quality of life in functional gastrointestinal disorders: Regulatory issues

European Journal of Surgery, Supplement

Volumn 164, Issue 583, 1998, Pages 87-91

  Bergmann, Jean François ^a   Chassany, Olivier ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Clinical trials; Functional gastrointestinal disorders; Quality of life; Regulatory affairs

Indexed keywords

ARTICLE; GASTROINTESTINAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; SCORING SYSTEM; CONTROLLED CLINICAL TRIAL; HUMAN; IRRITABLE COLON; OUTCOME ASSESSMENT; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REVIEW; STANDARD;

PLACEBO;

COLONIC DISEASES, FUNCTIONAL; CONTROLLED CLINICAL TRIALS; GASTROINTESTINAL DISEASES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBOS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 0032216689     PISSN: 1102416X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 3-15.
2. Chassany O, Marquis P, Fraitag B, Scherrer B, Sapede C. European psychometric validation of a specific quality of life questionnaire in functional digestive disorders. Gut 1996; 99 (Suppl 3): A33.
3. Coons SJ, Kaplan RM. Issues in health policy. Assessing health-related quality of life: application to drug therapy. Clin Ther 1992; 14: 850-858.
4. Fullerton S, Gitnick G. Health-related quality of life, patient outcome, and managed care: the road ahead. Scand J Gastroenterol 1996; 31 (Suppl 221): 39-41.
5. Glise H, Hallerbäck B, Wiklund I. Quality of life: a reflection of symptoms and concerns. Scand J Gastroenterol 1996; 31 (Suppl 221): 14-17.
6. Hahn BA, Kirchdoerfer LJ, Fullerton S, Mayer E. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Aliment Pharmacol Ther 1997; 11: 547-552.
7. Harvey RF, Mauad EC, Brown AM. Prognosis in the irritable bowel syndrome: a 5-year prospective study. Lancet 1987; i: 963-965.
8. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-87.
9. Klein KB. Controlled treatment trials in the irritable bowel syndrome: a critique. Gastroenterology 1998; 95: 232-241.
10. Quality of life Evaluation Workshop: Quality of life evaluation - Abstracts - Drug inform J 1993; 27: 849-879.
11. Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Quality of Life Research 1996; 5: 496-502.
12. Talley NJ, Phillips SF, Melton LJ, Mulvihill C, Wiltgen C, Zinsmeister AR. Diagnostic value of the Manning criteria in irritable bowel syndrome. Gut 1990; 31: 77-81.
13. Whitehead WE, Burnett CK, Cook EW 3rd, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996; 41: 2248-2253.
14. Wiklund I. Quality of life and regulatory issues. Scand J Gastroenterol 1996; 31 (Suppl 221): 37-38.